Update in Lung Cancer and Oncological Disorders 2010HALMOS, Balazs; POWELL, Charles A.American journal of respiratory and critical care medicine. 2011, Vol 184, Num 3, pp 297-302, issn 1073-449X, 6 p.Article

Update in Lung Cancer and Mesothelioma 2012POWELL, Charles A; HALMOS, Balazs; NANA-SINKAM, Serge P et al.American journal of respiratory and critical care medicine. 2013, Vol 188, Num 2, pp 157-166, issn 1073-449X, 10 p.Article

Structure and Clinical Relevance of the Epidermal Growth Factor Receptor in Human CancerKUMAR, Amit; PETRI, Edward T; HALMOS, Balazs et al.Journal of clinical oncology. 2008, Vol 26, Num 10, pp 1742-1751, issn 0732-183X, 10 p.Article

Dysregulation of the C/EBPα Differentiation Pathway in Human CancerKOSCHMIEDER, Steffen; HALMOS, Balazs; LEVANTINI, Elena et al.Journal of clinical oncology. 2009, Vol 27, Num 4, pp 619-628, issn 0732-183X, 10 p.Article

Cooperative interaction between protein inhibitor of activated signal transducer and activator of transcription-3 with epidermal growth factor receptor blockade in lung cancerKLUGE, Amy; DABIR, Snehal; KERN, Jeffrey et al.International journal of cancer (Print). 2009, Vol 125, Num 7, pp 1728-1734, issn 0020-7136, 7 p.Article

A Phase I Study of the combination of oxaliplatin/docetaxel and vandetanib for the treatment of advanced gastroesophageal cancerHALMOS, Balazs; YUXIA JIA; BOKAR, Joseph A et al.Investigational new drugs. 2013, Vol 31, Num 5, pp 1244-1250, issn 0167-6997, 7 p.Article

Combined Vascular Endothelial Growth Factor Receptor and Epidermal Growth Factor Receptor (EGFR) Blockade Inhibits Tumor Growth in Xenograft Models of EGFR Inhibitor ResistanceNAUMOV, George N; NILSSON, Monique B; JÄNNE, Pasi et al.Clinical cancer research (Print). 2009, Vol 15, Num 10, pp 3484-3494, issn 1078-0432, 11 p.Article

Immunohistochemical analysis of C/EBPα in non-small cell lung cancer reveals frequent down-regulation in stage II and IIIa tumors : A correlative study of e3590COSTA, Daniel B; SIGUI LI; KOCHER, Olivier et al.Lung cancer. 2007, Vol 56, Num 1, pp 97-103, issn 0169-5002, 7 p.Article

Mechanism of lovastatin-induced apoptosis in intestinal epithelial cellsAGARWAL, Banke; HALMOS, Balazs; FEOKTISTOV, Aleksander S et al.Carcinogenesis (New York. Print). 2002, Vol 23, Num 3, pp 521-528, issn 0143-3334Article

MET-Independent Lung Cancer Cells Evading EGFR Kinase Inhibitors Are Therapeutically Susceptible to BH3 Mimetic AgentsWEIWEN FAN; ZHE TANG; HOWELL, Scott et al.Cancer research (Chicago, Ill.). 2011, Vol 71, Num 13, pp 4494-4505, issn 0008-5472, 12 p.Article

A rapid and sensitive enzymatic method for epidermal growth factor receptor mutation screeningJÄNNE, Pasi A; BORRAS, Ana M; DISTEL, Robert J et al.Clinical cancer research. 2006, Vol 12, Num 3, pp 751-758, issn 1078-0432, 8 p., 1Article

Dual specificity phosphatase 6 (DUSP6) is an ETS-regulated negative feedback mediator of oncogenic ERK signaling in lung cancer cellsZHENFENG ZHANG; KOBAYASHI, Susumu; BORCZUK, Alain C et al.Carcinogenesis (New York. Print). 2010, Vol 31, Num 4, pp 577-586, issn 0143-3334, 10 p.Article

Effects of Erlotinib in EGFR Mutated Non-Small Cell Lung Cancers with Resistance to GefitinibCOSTA, Daniel B; NGUYEN, Kim-Son H; HUBERMAN, Mark S et al.Clinical cancer research (Print). 2008, Vol 14, Num 21, pp 7060-7067, issn 1078-0432, 8 p.Article

Differential effects of gefitinib and cetuximab on non-small-cell lung cancers bearing epidermal growth factor receptor mutationsMUKOHARA, Toru; ENGELMAN, Jeffrey A; TENEN, Daniel G et al.Journal of the National Cancer Institute. 2005, Vol 97, Num 16, pp 1185-1194, issn 0027-8874, 10 p.Article

Activating mutations of the Noonan syndrome-associated SHP2/PTPN11 gene in human solid tumors and adult acute myelogenous leukemiaBENTIRES-ALJ, Mohamed; PAEZ, J. Guillermo; RICHARDS, William G et al.Cancer research (Baltimore). 2004, Vol 64, Num 24, pp 8816-8820, issn 0008-5472, 5 p.Article

PIAS3 activates the intrinsic apoptotic pathway in non-small cell lung cancer cells independent of p53 statusDABIR, Snehal; KLUGE, Amy; MCCOLL, Karen et al.International journal of cancer (Print). 2014, Vol 134, Num 5, pp 1045-1054, issn 0020-7136, 10 p.Article

Activation of the AXL kinase causes resistance to EGFR-targeted therapy in lung cancerZHENFENG ZHANG; JAE CHEOL LEE; YUN JUNG CHOI et al.Nature genetics. 2012, Vol 44, Num 8, pp 852-860, issn 1061-4036, 9 p.Article

Genetic Abnormalities of the EGFR Pathway in African American Patients With Non-Small-Cell Lung CancerLEIDNER, Rom S; PINGFU FU; HIRSCH, Fred R et al.Journal of clinical oncology. 2009, Vol 27, Num 33, pp 5620-5626, issn 0732-183X, 7 p.Article

15-Hydroxyprostaglandin Dehydrogenase Is a Target of Hepatocyte Nuclear Factor 3β and a Tumor Suppressor in Lung CancerGUOSHENG HUANG; EISENBERG, Rosana; TENEN, Daniel G et al.Cancer research (Baltimore). 2008, Vol 68, Num 13, pp 5040-5048, issn 0008-5472, 9 p.Article

Resistance to an Irreversible Epidermal Growth Factor Receptor (EGFR) Inhibitor in EGFR-Mutant Lung Cancer Reveals Novel Treatment StrategiesZHIWEI YU; BOGGON, Titus J; KOBAYASHI, Susumu et al.Cancer research (Baltimore). 2007, Vol 67, Num 21, pp 10417-10427, issn 0008-5472, 11 p.Article

Transcriptional profiling identifies cyclin D1 as a critical downstream effector of mutant epidermal growth factor receptor signalingKOBAYASHI, Susumu; SHIMAMURA, Takeshi; HALMOS, Balazs et al.Cancer research (Baltimore). 2006, Vol 66, Num 23, pp 11389-11398, issn 0008-5472, 10 p.Article

Phase II trial of Sorafenib in conjunction with chemotherapy and as maintenance therapy in extensive-stage small cell lung cancerSHARMA, Neelesh; PENNELL, Nathan; NICKOLICH, Myles et al.Investigational new drugs. 2014, Vol 32, Num 2, pp 362-368, issn 0167-6997, 7 p.Article

An alternative inhibitor overcomes resistance caused by a mutation of the epidermal growth factor receptorKOBAYASHI, Susumu; HONGBIN JI; YUZA, Yuki et al.Cancer research (Baltimore). 2005, Vol 65, Num 16, pp 7096-7101, issn 0008-5472, 6 p.Article

Uncommon presentations of some common malignancies: Case 1: Sequential paraneoplastic endocrine syndromes in small-cell lung cancerMAYER, Stephen; CYPESS, Aaron M; KOCHER, Olivier N et al.Journal of clinical oncology. 2005, Vol 23, Num 6, pp 1312-1314, issn 0732-183X, 3 p.Article

EGFR mutation and resistance of non-small-cell lung cancer to gefitinibKOBAYASHI, Susumu; BOGGON, Titus J; DAYARAM, Tajhal et al.The New England journal of medicine. 2005, Vol 352, Num 8, pp 786-792, issn 0028-4793, 7 p.Article